HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon

This article was originally published in The Rose Sheet

Executive Summary

Revenues growth expected in 8%-9% range for second quarter with U.S. sales gains in 5%-6% range, CEO Andrea Jung tells a Strategic Decisions Conference sponsored by Sanford Bernstein June 7. For the full year, Avon sales are in line with targets of mid-single digit sales rise and earnings-per-share increase in the low to mid-teens, the exec reports. Avon's new business strategies are key drivers behind the revenue growth, Jung says. The company is investing $100 mil. to boost its brand image, including the "Let's Talk" global ad campaign (1"The Rose Sheet" Dec. 13, 1999, p. 7). Avon also is in talks with potential retail partners and will target teens via the Internet with new products (2"The Rose Sheet" April 24, p. 5)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel